Nutex Health (NUTX)
(Delayed Data from NSDQ)
$93.59 USD
+2.44 (2.68%)
Updated Aug 6, 2025 04:00 PM ET
After-Market: $93.59 0.00 (0.00%) 4:44 PM ET
NA Value
NA Growth NA Momentum NA VGMFundamental Charts
About Price to Cash Flow
The Price to Cash Flow ratio or P/CF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or overvalued with the denominator being cash flow. One of the reasons why some investors prefer the P/CF ratio over the P/E ratio is because the net income of the cash flow portion rightly adds depreciation and amortization back in since these are not cash expenditures. In contrast, the net income that goes into the earnings portion of the P/E ratio does not add these in, thus artificially reducing the income and skewing the P/E ratio. Like the P/E ratio, a lower number is considered better. A value under 20 is generally considered good.
NUTX 93.59 +2.44(2.68%)
Will NUTX be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for NUTX based on the 1-3 month trading system that more than doubles the S&P 500.
Other News for NUTX
Staying On The Sidelines With Nutex Health: Impressive Growth, Serious Doubts Remain
NUTEX HEALTH TO RING NASDAQ BELL AND MEET WITH INVESTORS IN NYC ON AUGUST 26 | NUTX Stock News
12 Health Care Stocks Moving In Wednesday's Intraday Session
Nutex Health 'strongly disagrees' with allegations in short report
Nutex Health (NUTX) Refutes Claims from Recent Short Seller Report | NUTX Stock News